International Journal of Modern Organic Chemistry, 2013, 2(1): 11-25 International Journal of Modern Organic Chemistry ISSN: 2166-0174

Florida, USA Journal homepage: www.ModernScientificPress.com/Journals/ijorgchem.aspx Article

Reactivity of Oxazolone Derivative towards Nitrogen and Carbon Nucleophilic Reagents: Applications to the Synthesis of New Heterocycles
Osman M. O. Habib, Hussein M. Hassan, Evelin B. Moawad and Ahmed El-Mekabaty* Department of Chemistry, Faculty of Science, Mansoura University, Mansoura 35516, Egypt * Author to whom correspondence should be addressed; E-Mail: a_el_m11@yahoo.com; elmekabaty@mans.edu.eg; Tel: (+2010)03677361. Article history: Received 7 January 2013, Received in revised form 23 January 2013, Accepted 25 January 2013, Published 28 January 2013.

Abstract: Oxazolone derivative 2 was utilized as a key intermediate for the synthesis of some new oxazolone and imidazolone derivatives. Reaction of 2 with diamines under different conditions gives the corresponding imidazolone derivatives 3-8, respectively. In addition, its reaction with some heterocyclic amines in glacial acetic acid gives the corresponding imidazolone derivatives 9-14, respectively. Moreover, cyclocondensation of thiosemicarbazide with 2 in dry pyridine afforded 15. Furthermore, addition of secondary amines to the olefinic double bond of compound 2 gives the corresponding addition products 16-19, respectively. Finally, Michael addition of oxazolone 2 with some active methylene compounds afforded oxazolone derivatives 20-23, respectively. Keywords: Oxazolone; Imidazolone; Pyrazole; Benzoimidazole.

1. Introduction
The Erlenmeyer reaction was first described in 1893 by Friedrich Gustav Carl Emil Erlenmeyer1 who condensed benzaldehyde with N-acetyl glycine in the presence of acetic anhydride and sodium acetate. The reaction goes via a Perkin condensation following the initial cyclization of the N-acetylglycine yielding the so-called Erlenmeyer azlactones. Erlenmeyer azlactones have been used in a wide variety of reactions as precursors for biologically active peptides, herbicides, fungicides, and
Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

12

as drugs, pesticides and agrochemical intermediates. Oxazol-5-ones inhibit the activity of tyrosinase enzyme with a maximum inhibition by the derivative which bears a cinnamoyl residue at C-4 of oxazolone moiety. Some prepared 3,4-diaryloxazolones showed inhibition of cyclooxygenase-2 (COX2), in vivo anti-inflammatory and excellent activities of arthritis and hyperalgesia [1-5]. Several imidazolidine derivatives are proved as insecticides such as imidazolidin-2-one and imidaclopride; herbicides as imazamethabenz-methyl and oxadiargyl and fungicides as iprodione that controlled the brown patch (Rhizoctonia solani) [6]. Great fungitoxic effect was exhibited by imidazole derivatives that posses an electron-attracting moietysubstituted on the imine nitrogen atom [7]. On the other hand, it has been stated that compounds containing aromatic sulfonate or sulfonamide moieties possess high acaricidal as well as insecticidal activity [8-9]. In view of the aforementioned facts, taking these structural features into consideration and as a continuation of our previous work on the chemistry of heterocyclic compounds [10-12], we report herein the synthesis of some heterocyclic systems bearing both aryl sulfonate, oxazolone and imidazolone moieties in the same molecule, as new compounds in this field, of anticipated biological activities.

2. Materials and Methods

2.1. Instruments All melting points (uncorrected) were determined on Gallenkamp electric melting point apparatus, FTIR spectra (KBr disk) were recorded on a Nicolet Magna. IR model 550 spectrophotometers, 1H-NMR spectra, were determined on Brucker Wpsy 300 MHZ spectrometer with TMS as internal standard and the chemical shifts are in ppm. Mass spectra were recorded at 70 ev with a varian MAT 311. Elemental analyses are satisfactory for all synthesized compounds (2-23), all analyses were carried out in Faculty of Science, Cairo University, Egypt. ( Z)-4-((5oxo-2phenyloxazol-4(5H)ylidene)methyl)phenyl-4-methylbenzene sulfonate 2 was prepared previously as shown in literature [13]. 2.2. Synthesis 2.2.1. Reaction of oxazolone (2) with o-phenylenediamine a) By fusion at 140 C and 190 C A mixture of oxazolone 2 (0.003 mol), o-phenylenediamine (0.003 mol) and freshly fused sodium acetate (0.2 gm) was fused at 140 C and/or 190 C for 3 h. In each case, the reaction mixture was cooled, washed with dil. HCl, and the separated solid product was dried and recrystallized from methanol to give 3 and 4, respectively.

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25 4-(2-benzamido-2-(1H-benzo[d]imidazol-2-yl)vinyl)phenyl4-methylbenzenesulfonate (3):

13

Gray powder; Yield 53%; m.p. 149-151oC. IR (KBr): /cm-1: 1680 (CO, amidic), 3174-3289 (2NH), 1360 (SO3), 1600 (C=N), 1590 (C=C). EIMS (m/z) (%): 509 (M+, 20), 422 (54), 353 (23), 268 (11), 263 (16), 191 (32), 104 (100), 77 (37). Anal. for C29H23N3O4S (509.5): Calcd.: C, 68.35%; H, 4.55%; N, 8.25 %. Found: C, 68.31%; H, 4.50%; N, 8.15 %. (Z)-4-((1-phenyl-3H-benzo[d]imidazo[1,5-a]imidazol-3-ylidene)methyl)phenyl-4-methylbenzene sulfonate (4): Brown powder; Yield 63%; m.p. 238-240oC. IR (KBr): /cm-1: 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 489 (M+-2, 18), 341 (38), 295 (25), 213 (40), 193 (48), 147 (73), 91 (38), 44 (100). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 7.1-8.2 (m, 18H, Ar-H, CH=C). Anal. for C29H21N3O3S (491.5): Calcd.: C, 70.86%; H, 4.31%; N, 8.55%. Found: C, 70.81%; H, 4.30%; N, 8.45%. b) By refluxing in ethyl alcohol (Z)-4-(3-((2-aminophenyl)amino)-2-benzamido-3-oxoprop-1-en-1-yl)phenyl-4-methylbenzene sulfonate (5) A mixture of oxazolone 2 (0.003 mol) and o-phenylenediamine (0.003 mol) in absolute ethanol (20 mL) was refluxed for 6 h. The solid product that separated on cooling was filtered off and recrystallized from ethanol to give 5: Grey powder; Yield 65%; m.p. 218-220oC. IR (KBr): /cm-1: 1680 (CO, amidic), 3430, 3490 (2NH), 3225-3370 (NH2), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%) : 527 (M+, 30), 495 (11), 480 (14), 422 (27), 380 (56), 268 (16), 253 (100), 105 (52). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 4.5 (br, 2H, NH2), 6.9-8.3 (m, 20H, Ar-H, CH=C, 2NHCO). Anal. for C29H25N3O5S (527.5): Calcd.: C, 66.02%; H, 4.78%; N, 7.96%. Found: C, 66.01%; H, 4.80%; N, 7.86%. c) By refluxing in glacial acetic acid (Z)-4-((1-(2-acetamidophenyl)-5-oxo-2-phenyl-1H-imidazol-4(5H)-ylidene)methyl)phenyl-4-methyl benzenesulfonate (6) A mixture of oxazolone 2 (0.003 mol) and o- phenylenediamine (0.003 mol) in glacial acetic acid (20 mL) containing freshly fused sodium acetate (0.2 gm) was heated under reflux for 7 h. The reaction mixture was left to cool, and then poured over ice; the solid that separated out was filtered off, dried and recrystallized from ethanol-ether affording 6: Yellow powder; Yield 65%; m.p. 180-182oC. IR (KBr): /cm-1: 1698 (CO, amidic), 1665 (CONH), 3133 (NH), 1360 (SO3), 1610 (C=N). EIMS (m/z) (%): 551 (M+, 45), 451 (42), 368 (25), 282 (26), 197 (19), 148 (40), 78 (51), 63 (100). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 2.2 (s, 3H, CH3CO),

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

14

7.1-8.2 (m, 19H, Ar-H, CH=C, NH). Anal. for C31H25N3O5S (551.6): Calcd.: C, 67.5%; H, 4.57%; N, 7.62%. Found: C, 67.4%; H, 4.50%; N, 7.65%. 2.2.2. Synthesis of (Z)-4-((1-(4-acetamidophenyl)-5-oxo-2-phenyl-1H-imidaz-ol-4(5H)-ylidene) methyl)phenyl-4-methylbenzenesulfonate (7) A mixture of oxazolone 2 (0.003 mol) and p- phenylenediamine (0.003 mol) in glacial acetic acid (30 mL) containing freshly fused sodium acetate (0.2 gm) was heated under reflux for 5 h. The reaction mixture was left to cool; the solid that separated was filtered off, dried and recrystallized from acetic acid affording 7: Yellow powder; Yield 80%; m.p. 225-227oC. IR (KBr): /cm-1: 1700 (CO, amidic), 1660 (CON), 3350 (NH), 1360 (SO3), 1640 (C=N). EIMS (m/z) (%): 552 (M+, 15), 446 (12), 342 (15), 256 (25), 157 (16), 109 (35), 84 (63), 40 (100). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 2.6 (s, 3H, CH3CO), 7.1-8.4 (m, 19H, Ar-H, CH=C, NH). Anal. for C31H25N3O5S (551.6): Calcd.: C, 67.5%; H, 4.57%; N, 7.61%. Found: C, 67.1%; H, 4.49%; N, 5.62%. 2.2.3. Synthesis of ((1Z,1'Z)-(1,1'-(1,4-phenylene)bis(5-oxo-2-phenyl-1H-imidazole-1(5H)-yl-4-(5H)yli dene))bis(methanylylidene))bis(4,1-phenylen- e)bis(4-methylbenzenesulfonate) (8) A mixture of oxazolone 2 (0.006 mol) and p- phenylenediamine (0.003 mol) in glacial acetic acid (30 mL) containing freshly fused sodium acetate (0.5 gm) was heated under reflux for 8 h. The reaction mixture was left to cool, and then poured over ice, the solid that separated out was filtered off, dried and recrystallized from dimethylformamide affording the bis imidazolone 8: Grey powder; Yield 75%; m.p. 271-273oC. IR (KBr): /cm-1: 1675 -1688 (2CON), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 911 (M+, 22), 788 (33), 540 (11), 382 (100), 364 (44), 301 (8), 285 (53), 218 (17), 155 (25), 75 (33). 1H NMR (DMSO) (, ppm), 2.4 (br, 6H, 2CH3), 6.9-8.3 (m, 32H, Ar-H, 2CH=C). Anal. for C52H38N4O8S2 (911): Calcd.: C, 68.56%; H, 4.2%; N, 6.15%. Found: C, 68.48%; H, 4.1%; N, 6.11%. 2.2.4. Reaction of oxazolone (2) with heterocyclic amines A mixture of 2 (0.01 mol) and the appropriate heterocyclic amines namely 2-aminopyridine, 3aminopyridine, 2-aminothiazole, 2-amino benzothiazole, 4-aminoantipyrine and 3-amino-4-

(phenyldiazenyl)-1H-pyrazol-5(4H)-one (0.01 mol) and freshly fused sodium acetate (0.5 gm) in glacial acetic acid (40 mL) was refluxed for 5-8 h, then cooled and the reaction mixture was poured onto ice-water. The solids separated were filtered off and recrystallized from methanol to give imidazolone derivatives 9-14.

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

15

(Z)-4-((5-oxo-2-phenyl-1-(pyridin-2-yl)-1H-imidazol-4(5H)-ylidene)methyl)phenyl-4-methylbenzene sulfonate (9): Yellow crystals; Yield 62%; m.p. 158-160oC. IR (KBr): /cm-1: 1680 (CO, amidic), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 496 (M++1, 16), 267 (14), 232 (13), 195 (18), 153 (14), 101 (12), 86 (47), 74 (100). Anal. for C28H21N3O4S (495.5): Calcd.: C, 67.86%; H, 4.27%; N, 8.48 %. Found: C, 67.81%; H, 4.20%; N, 8.35 %. (Z)-4-((5-oxo-2-phenyl-1-(pyridin-3-yl)-1H-imidazol-4(5H)-ylidene)methyl)phenyl-4-methylbenzene sulfonate (10): Yellow powder; Yield 72%; m.p. 166-168oC. IR (KBr): /cm-1: 1680 (CO, amidic), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 495 (M+, 24), 378 (23), 256 (41), 202 (37), 184 (12), 126 (15), 88 (43), 58 (100). Anal. for C28H21N3O4S (495.5): Calcd.: C, 67.86%; H, 4.27%; N, 8.48%. Found: C, 67.78%; H, 4.25%; N, 8.49%. (Z)-4-((5-oxo-2-phenyl-1-(thiazol-2-yl)-1H-imidazol-4(5H)-ylidene)methyl)phenyl-4-methylbenzene sulfonate (11): Yellow powder; Yield 52%; m.p. 181-183oC. IR (KBr): /cm-1: 1680 (CO, amidic), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 501 (M+, 41), 445 (38), 404 (48), 388 (71), 347 (41), 294 (66), 263 (33), 191 (11), 105 (81), 58 (100). Anal. for C26H19N3O4S2 (501.5): Calcd.: C, 62.26%; H, 3.82%; N, 8.38%. Found: C, 62.28%; H, 3.80%; N, 8.28%. (Z)-4-((1-(benzo[d]thiazol-2-yl)-5-oxo-2-phenyl-1H-imidazol-4(5H)-ylidene)methyl)-phenyl-4methylbenzenesulfonate (12): Grey powder; Yield 60%; m.p. 163-165oC. IR (KBr): /cm-1: 1680 (CO, amidic), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 553 (M++2, 20), 423 (20), 383 (41), 305 (59), 256 (25), 227 (48), 186 (11), 156 (10), 122 (15), 75 (100). Anal. for C30H21N3O4S2 (551.6): Calcd.: C, 65.32%; H, 3.84%; N, 7.62 %. Found: C, 65.28%; H, 3.80%; N, 7.55 %. (Z)-4-((1-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-5-oxo-2-phenyl-1H-imidazol4(5H)-ylidene)methyl)phenyl 4-methylbenzenesulfonate (13): Yellow powder; Yield 42%; m.p. 194-196oC. IR (KBr): /cm-1: 1680 (CO, amidic), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 604 (M+, 32), 450 (13), 347 (26), 290 (11), 263 (16), 231 (39), 156 (62), 105 (100). Anal. for C34H28N4O5S (604.6): Calcd.: C, 67.53%; H, 4.67%; N, 9.27%. Found: C, 67.58%; H, 4.60%; N, 9.24%. 4-((1Z)-(5-oxo-1-(5-oxo-4-(phenyldiazenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2-phenyl-1H-imidazol-4 (5H)-ylidene)methyl)phenyl 4-methylbenzenesulfonate (14): Yellow powder; Yield 46%; m.p. 172-174oC. IR (KBr): /cm-1: 1680 (CO, amidic), 3320 (NH), 1360 (SO3), 1620 (C=N). EIMS (m/z) (%): 605 (M+, 21), 495 (16), 449 (12), 369 (23), 255 (12), 196 (16),
Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

16

104 (73), 91 (100). Anal. for C32H24N6O5S (604.6): Calcd.: C, 63.57%; H, 4.0%; N, 13.90%. Found: C, 63.58%; H, 3.80%; N, 13.88%. 2.2.5. Synthesis of (Z)-4-((5-phenyl-2-thioxo-2H-imidazo[1,5-b][1,2,4]triazol-7(3H)-ylidene)methyl) phenyl-4-methylbenzenesulfonate (15) To a solution of 2 (0.01 mol) in 30 ml dry pyridine, thiosemicarbazide (0.03 mol) was added and the reaction mixture was heated under reflux for 8 h, left to cool, poured onto cold water with stirring. The solid product was filtered off, washed with water several times and recrystallized from dimethylformamide to give 15: Grey powder; Yield 41%; m.p. 181-183oC. IR (KBr): /cm-1: 1376 (C=S), 3442 (NH), 1340 (SO3), 1640 (C=N). EIMS (m/z) (%): 475 (M+, 42), 411 (75), 320 (18), 275 (53), 167 (57), 139 (27), 91 (100), 50 (49). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 9.8 (s, 1H, NH), 7.2-8.3 (m, 14H, Ar-H, CH=C). Anal. for C24H18N4O3S2 (474.5): Calcd.: C, 60.74%; H, 3.82%; N, 11.81 %. Found: C, 60.71%; H, 3.79%; N, 11.78 %. 2.2.6. Reaction of oxazolone (2) with secondary amines and thiophenol A mixture of oxazolone 2 (0.05 mol) and the appropriate reagent namely piperidine, morpholine, piperazine, and thiophenol (0.05 mol) in dry benzene (30 mL) was heated at 60C with stirring for 3-5 h. The reaction mixture were left to stand overnight at room temperature, then petroleum ether (40-60C) was added and the precipitated solid products were filtered off and recrystallized from benzene-hexane (2:1) to give 16-19 respectively. 4-((5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)(piperidin-1-yl)methyl)phenyl-4-methylbenzene sulfonate (16): Yellow powder; Yield 25%; m.p. 186-188oC. IR (KBr)max. cm-1: 1770 (CO, lactone), 1644 (C=N), 1360 (SO3). EIMS (m/z) (%): 504 (M+, 12), 478 (7.1), 365 (58), 282 (10), 161 (14), 85 (100), 72 (28).
1

H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 2.46-2.47 (t, 4H, N(CH2)2), 1.48-1.49 (m, 6H, 3CH2 of

piperidine), 4.51-4.52 (m, 2H, N-CH, CH of oxazolone), 6.9-8.1 (m, 14H, Ar-H, CH=C). Anal. for C28H28N2O5S (504.6): Calcd.: C, 66.65%; H, 5.59%; N, 5.55%. Found: C, 66.55%; H, 5.55%; N, 5.54%. 4-(morpholino(5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)methyl)phenyl-4-methylbenzenesulfonate (17): Yellow powder; Yield 31%; m.p. 160-162oC. IR (KBr)max. cm-1: 1780 (CO, lactone), 1640 (C=N), 1360 (SO3). EIMS (m/z) (%): 506 (M+, 16), 420 (16), 265 (19), 161 (100), 117 (45), 93 (46), 57 (18).
1

H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 2.67-2.68 (t, 4H, N(CH2)2), 3.58-3.59 (t, 4H, O(CH2)2),

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

17

4.51-4.52 (m, 2H, N-CH, CH of oxazolone), 6.9-8.1 (m, 14H, Ar-H, CH=C). Anal. for C27H26N2O6S (506.5): Calcd.: C, 64.02%; H, 5.17%; N, 5.53%. Found: C, 64.0%; H, 5.15%; N, 5.53%. 4-((5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)(piperazin-1-yl)methyl)phenyl-4-methylbenzene sulfonate (18): Yellow powder; Yield 34%; m.p. 221-223oC. IR (KBr)max. cm-1: 1780 (CO, lactone), 3423 (NH), 1638 (C=N), 1360 (SO3). EIMS (m/z) (%): 505 (M+, 22), 441 (26), 395 (52), 315 (12), 277 (53), 200 (61), 148 (79), 105 (100), 48 (61). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 2.65-2.66 (m, 8H, N(CH2)4), 4.51-4.52 (m, 2H, N-CH, CH of oxazolone), 6.9-8.1 (m, 15H, Ar-H, CH=C, NH). Anal. for C27H27N3O5S (505.5): Calcd.: C, 64.14%; H, 5.38%; N, 8.31%. Found: C, 64.13%; H, 5.35%; N, 8.24%. 4-((5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)(phenylthio)methyl)phenyl-4-methylbenzenesulfonate (19): Yellow powder; Yield 41%; m.p. 196-198oC. IR (KBr)max. cm-1: 1780 (CO, lactone), 1640 (C=N), 1360 (SO3). EIMS (m/z) (%): 529 (M+, 25), 401 (19), 316 (47), 257 (29), 213 (37), 188 (15), 101 (12), 77 (20), 43 (100). Anal. for C29H23NO5S2 (529.6): Calcd.: C, 65.77%; H, 4.38%; N, 2.64%. Found: C, 65.73%; H, 4.35%; N, 2.54%. 2.2.7. Synthesis of ethyl2-cyano-3-(5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)-3-(4-(tosyloxy)phenyl) propanoate (20) A mixture of oxazolone 2 (0.03 mol), ethylcyanoacetate (0.05 mol) and few drops of piperidine in dry chloroform (50 mL) was heated under reflux for 8 hours. The solvent was evaporated under reduced pressure; the obtained solid product was filtered off, and recrystallized from methanol to furnish 20: Yellow powder; Yield 28%; m.p. 297-299oC. IR (KBr)max. cm-1: 1780 (CO, lactone), 1730 (CO, ester), 2110 (CN), 1640 (C=N), 1360 (SO3). EIMS (m/z) (%): 533 (M+, 10), 413 (19), 341 (42), 304 (25), 280 (14), 189 (17), 168 (42), 105 (44), 77 (59), 43 (100). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 1.29-1.30 (t, 3H, CH3CH2), 4.37-4.43 (q, 2H, CH3CH2), 4.31-4.32 (m, 3H, CH-CH, CH of oxazolone), 6.9-8.1 (m, 14H, Ar-H, CH=C). Anal. for C28H24N2O7S (532.5): Calcd.: C, 63.15%; H, 4.54%; N, 5.25%. Found: C, 63.13%; H, 5.55%; N, 5.21%. 2.2.8. Synthesis of 2-acetyl-4-benzamido-3-(4-(tosyloxy)phenyl)pentanedioic acid (21) A mixture of 2 (0.005 mol) and ethylacetoacetate (0.01 mol) in 30ml ethanol was added dropwise to 10 mL sodium hydroxide (10%), the mixture was stirred at room temperature for 24 h then poured onto 5ml of 5% HCl. The formed solid was filtered, washed with water and recrystallized from ethanol to give 21:

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

18

White powder; Yield 51%; m.p. 285-287oC. IR (KBr)max. cm-1: 1670 (CO, amidic), 1700 (CO), 3400 (OH), 3300 (NH), 1640 (C=N), 1360 (SO3). EIMS (m/z) (%): 539 (M+, 46), 457 (10), 382 (100), 298 (10), 254 (35), 181 (27), 147 (16), 111 (15), 91 (56). Anal. for C27H25NO9S (539.5): Calcd.: C, 60.10%; H, 4.67%; N, 2.60 %. Found: C, 60.13%; H, 4.65%; N, 2.54 %. 2.2.9. Synthesis of 4-(2-nitro-1-(5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)alkyl)phenyl-4-methyl benzenesulfonate (22 and 23) A mixture of compound 2 (0.005 mol) , the appropriate nitroalkane namely, nitromethane and/or nitroethane (0.01 mol) and few drops of triethylamine in ethanol (30 mL) was refluxed with stirring for 12 h, then poured onto ice-water, The solid that separated was filtered off and recrystallized from ethanol to give 22, 23. 4-(2-nitro-1-(5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)ethyl)phenyl-4-methylbenzenesulfonate (22): Yellow crystal; Yield 38%; m.p. 205-207oC. IR (KBr)max. cm-1: 1770 (CO, lactone), 1350 (NO2), 1640 (C=N), 1360 (SO3). EIMS (m/z) (%): 482 (M++2, 19), 411 (28), 344 (36), 218 (55), 275 (100), 197 (45), 155 (47), 129 (46), 91 (67). Anal. for C24H20N2O7S (480.4): Calcd.: C, 59.99%; H, 4.20%; N, 5.83%. Found: C, 60.03%; H, 4.25%; N, 5.84%. 4-(2-nitro-1-(5-oxo-2-phenyl-4,5-dihydrooxazol-4-yl)propyl)phenyl-4-methylbenzene sulfonate (23): Yellow crystal; Yield 25%; m.p. 165-167oC. IR (KBr)max. cm-1: 1770 (CO, lactone), 1350 (NO2), 1640 (C=N), 1360 (SO3). EIMS (m/z) (%): 495 (M+, 23), 455 (16), 419 (80), 384 (46), 350 (63), 334 (12), 295 (60), 238 (100), 155 (36). 1H NMR (DMSO) (, ppm), 2.4 (s, 3H, CH3), 1.7 (d, 3H, CH3CH), 3.3 (t, 1H, CH), 4.31-4.32 (m, 2H, O2NCH-, CH of oxazolone), 6.9-8.1 (m, 14H, Ar-H, CH=C). Anal. for C25H22N2O7S (494.5): Calcd.: C, 60.72%; H, 4.48%; N, 5.66%. Found: C, 60.73%; H, 4.45%; N, 5.56%.

3. Results and Discussion

3.1. Synthesis The required (Z)-4-((5oxo-2-phenyloxazol-4(5H)ylidene)methyl)phenyl-4-methyl benzene sulfonate 2, was prepared by means of the reaction of 4-toluenesulfonyloxy benzaldehyde 1 with hippuric acid and acetic anhydride in the presence of freshly fused sodium acetate according to the method reported in literature [13] (Scheme 1).

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

19

Scheme 1. Synthesis of oxazolone derivative 2

Synthesis of benzimidazole ring is an important pharmacophore in modern drug discovery [14]. Benzimidazole derivatives exhibit significant activity against several viruses such as HIV [15-16], herps (HSV-1) [17], RNA [18] and influenza [19]. Therefore, a part of this program was to synthesize these compounds starting with oxazolone derivative 2. Fusion of 2 with o-phenylenediamine in the presence of freshly fused sodium acetate at 140 oC and 190 oC gives different products. When fusion was carried out at 140oC, compound 3 was obtained, while fusion at 190 oC leads to the formation of 4. Structures 3 and 4 were based on correct analytical results. The IR spectrum of 3 showed stretching frequencies at 1680, 3174-3289, and 1590 cm-1 attributable to the amidic (CO), (2NHCO), and (C=C) groups, respectively, the IR spectrum of 4 revealed absorption bands at 1620 cm-1 attributable for (C=N), group. The bands characteristic for the C=O and NH2 groups disappeared. Next, reaction of oxazolone 2 with o-phenylenediamine in absolute ethanol under reflux afforded 5. The IR spectrum showed stretching frequencies at 3225-3370 and 1680 cm-1 attributable to the (NH2), amidic (CO), groups, respectively. 1H-NMR showed signals at 2.4 (s, 3H, CH3), 4.5 (br, 2H, NH2), 6.9-8.3 (m, 20H, Ar-H, CH=C, 2NHCO). In the context of this program and because of increased interest in imidazolone derivatives, some new imidazolone derivatives were required for the study of their efficiency as anticipated biological activities. Oxazolone derivative 2 seemed to be a good precursor to fulfill this objective via its reactions with some nucleophilic reagents. Treatment of 2 with ophenylenediamine in glacial acetic acid under reflux in the presence of fused sodium acetate gives imidazolone derivative 6. The IR spectrum of compound 6 showed absorption bands at 3133 and 1698 cm-1 due to (NH) and (CONH) groups. The 1H-NMR spectrum revealed singlet signals at 8.2 and 2.2 characteristic for (NHCO) and (COCH3) protons, respectively. Besides, the mass spectrum showed the molecular ion peak at m/e 551(M+) (Scheme 2).

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

Ar HN Ph O O H2N HN EtOH 140oC N Ar C C H NH N Ph H O

20

Ar

CH N

O HN 2 + O H2N Ph

Ar

CH N Ph

O N

HN COCH3 AcOH

2
190oC

Ar CH N Ph

N N

Ar = H3C

O S O O

Scheme 2. Reaction of oxazolone 2 with o-phenylenediamine under different conditions On the other hand, refluxing of one mol of oxazolone 2 with one mol of p-phenylenediamine in the presence of glacial acetic acid and fused sodium acetate, afforded 7. However, using two mol of compound 2 to one mol of the other gives bis imidazolone 8. The structure of compounds 7 and 8 was confirmed by analytical as well as spectral data. The IR spectrum of 7 showed absorption bands at 3350 and 1700 cm-1 due to (NH) and (CONH) groups. The IR spectrum of 8 showed absorption bands at 1675 and 1688 cm-1 due to two (CON) groups. The 1H-NMR spectrum of 7 revealed singlet signals at 8.2 and 2.6 characteristic for (NHCO) and (COCH3) protons, respectively. In addition, the mass spectrum of compounds 7 and 8 showed the molecular ion peak at m/e 552 (M+) and 911 (M+), respectively (Scheme 3).

Scheme 3. Reaction of oxazolone 2 with p-phenylenediamine under different moles Pyridine, thiazole, benzothiazole and pyrazole derivatives are biologically interesting molecules that have established utility in the pharmaceutical and the agrochemical industries. Compounds with these ring systems have diverse pharmacological activity such as antitumor, anticonvulsant, antiviral, antimicrobial and fungicidal activities [19-20]. Encouraged by the above observations, it was planned
Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

21

to study structure variation by attaching some biologically active heterocycles such as Pyridine, thiazole, benzothiazole and pyrazole rings at position 1 of the main oxazolone moiety. These combinations were suggested in an attempt to investigate the possible synergistic influence of such structure hybridizations on the anticipated activity, hoping to discover a new lead structure that would have a significant antimicrobial activity at very small concentration. As a result, imidazolone derivatives 9-14, respectively could be achieved on treatment of 2 with some heterocyclic amines namely; 2-aminopyridine, 3aminopyridine, 2-aminothiazole, 2aminobenzothiazole, 4amino antipyrine and 5-amino-4-phenylazo-2,4-dihydropyrazol-3-one in glacial acetic acid and fused sodium acetate. The IR spectrum in general showed absorption bands at 1680 cm-1 due to CON group and the disappearance of the band characteristic for carbonyl of lactone group (Scheme 4).

Scheme 4. Reaction of oxazolone 2 with different heterocyclic amines On the other hand, synthesis of 1,2,4-triazoles fused to another heterocyclic ring has attracted wide spread attention due to their diverse applications as antibacterial-, antidepressant-, antiviral-, antitumorial- and anti-inflammatory agents, pesticides, herbicides dyes, lubricant and analytical reagents [21-23]. Among these, the commonly known systems are generally triazoles fused to imidazoles. In the present study Cyclocondensation of thiosemicarbazide with oxazolone 2 in dry pyridine afforded (Z)-4-((5-phenyl-2-thioxo-2H-imidazo[1,5-b][1,2,4]triazol-(3H)-ylidene)methyl)

phenyl-4-methyl benzenesulfonate 15. Structure 15 was inferred by its correct elemental analysis and spectroscopic data. The IR spectrum showed stretching frequencies at 3442 and 1376 cm -1 attributable to the (NH) and (C=S) groups, respectively. 1H-NMR showed signals at 2.4 (s, 3H, CH3), 9.8 (s, 1H, NH), 7.2-8.3 (m, 14H, Ar-H, CH=C). Beside, the mass spectrum revealed molecular ion peak at m/e 475 (M+) with relative abundance corresponding to the molecular formula C24H18N4O3S2 (Scheme 5).
Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

22

Scheme 5. Reaction of oxazolone 2 with thiosemicarbazide The reactivity of the exocyclic (C=C) bond in the four position of the oxazolone ring is due to conjugation with the adjacent carbonyl group [8]. In the present work, the addition of piperidine, morpholine, piperazine and thiophenol to the olefinic double bond in the four position of compound 2 gives the corresponding addition products 16-19, respectively (Scheme 6).
H N N Ar 18 N O O Ph 2 S Ar N 19 HN NH N

HN

O O Ph

Dry Benzene 600C

Dry Benzene Ar N 600C 16 O N

O O Ph

HS Dry Benzene 600C

O N O Ph

HN

Ar

Dry Benzene 600C O S O O

17

Ar = H3C

Scheme 6. Reaction of oxazolone 2 with secondary amines and thiophenol The present investigation deals also with the Michael addition on the exocyclic double bond in compound 2. Thus addition of ethylcyanoacetate to compound 2 in chloroform afforded oxazolone derivative 20 but the addition of ethylacetoacetate in the presence of sodium hydroxide afforded compound 21. On the other hand, the nitroalkanes are known to add to the (C=C) bond in the ,unsaturated carbonyl compounds in the presence of a base catalyst. So, addition of nitro methane and nitro ethane to oxazolone 2 leads to the formation of compounds 22 and 23, respectively. The structure of compounds 22 and 23 were confirmed by analytical as well as spectral data. The IR spectrum in general showed absorption bands at 1770, 1350 and 1640 cm-1 due to carbonyl of lactone, NO2 and
Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

23

C=N groups. The 1H-NMR spectrum of 23 revealed 2.4 (s, 3H, CH3), 1.7 (d, 3H, CH3-CH), 3.3 (t, 1H, CH), 4.31-4.32 (m, 2H, O2NCH-, CH of oxazolone), 6.9-8.1 (m, 14H, Ar-H, CH=C). In addition, the mass spectrum of compounds 22 and 23 showed the molecular ion peak at m/e 482 (M++2) and 495 (M+), respectively (Scheme 7).
H Ar N 22 H3C Ar N Ph O CH3CH2NO2 Ethanol/Et3N NO2 O Ph O NO2 O CH3NO2 Ethanol/Et3N EtOOC NCCH2COOEt Dry Chloroform Ar N Ph COMe COOH HN 21 Ph O O CN O

2
HOOC CH3COCH2COOEt Ar Ethanol/ NaOH (10%) O S O O

20

23

Ar = H3C

Scheme 7. Reaction of oxazolone 2 with active methylene compounds

4. Conclusions
We reported herein the synthesis of some heterocyclic systems bearing both aryl sulfonate, oxazolone or imidazolone moieties in the same molecule as new compounds in this field of anticipated biological activities. Oxazolone derivative 2 was utilized as a key intermediate for the synthesis of some new oxazolone and imidazolone derivatives. It was prepared by means of the reaction of 4toluenesulfonyloxy benzaldehyde 1 with hippuric acid and acetic anhydride in the presence of freshly fused sodium acetate. Reaction of 2 with diamines and heterocyclic amines under different conditions gives the corresponding imidazolone derivatives 3-14, respectively. In addition, cyclocondensation of thiosemicarbazide with compound 2 in dry pyridine afforded 15. Moreover, the addition of secondary amines to the olefinic double bond of compound 2 gives the corresponding addition products 16-19, respectively. Finally, Michael addition of compound 2 with some active methylene compounds afforded oxazolone derivatives 20-23, respectively.

Potential Conflicts of Interest

The authors declare no conflict of interest.

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

24

References
[1] Khan KM, Mughal UR, Khan MT, Zia US, Choudhary MI., Oxazolones: new tyrosinase inhibitors; synthesis and their structure-activity relationships. Bioorganic and Medicinal Chemistry. 2006, 14: 6027-6033. [2] Mistry RN, Desai KR., Studies on Synthesis of Some Novel Heterocyclic Azlactone Derivatives and Imidazolinone Derivatives and their Antimicrobial Activity. E-Journal of Chem., 2005, 2: 42-51. [3] Aaglawe M J; Dhule SS, Bahekar SS, Wakte P S, shinde DB., Synthesis and Antibacterial Activity of Some Oxazolone Derivatives. J. Korean Chem. Soc., 2003, 47: 133-136. [4] Joshi H, Upadhyay P, Karia D, Baxi AJ., Synthesis of Some Novel Imidazolinones as Potent Anticonvulsant Agents. European Journal of Medicinal Chemistry, 2003, 38: 837-840. [5] Siddiqui SA, Bhusare SR, Jarikote DV, Pawar R, Vibhute PYB., New Novel Synthesis and Antibacterial Activity of 1-(Substituted phenyl)-2-phenyl-4-(3-halo, 4-hydroxy 5-methoxy benzylidene)-imidazole-5-ones. Bull. Korean Chem. Soc., 2001, 22: 1033-1036. [6] Fidanza MA, Dernoeden PH., Brown patch in perennial ryegrass as influenced by irrigation, fungicide and fertilizers.Crop Sci., 1996, 36: 1631-1638. [7] Ahmed SA., Pesticidal Effects of Some Imidazolidine and Oxazolone Derivatives. World Journal of Agricultural Sciences., 2009, 5: 105-113. [8] Habib OMO, Moawad EB, El-Morsy SS., Synthesis of Some New Heterocyclic Conpounds with Expected Potential Biological Activity. Journal of Islamic Academy of Sciences., 1989, 2: 135138. [9] Habib OMO, Girges MM, Moawad EB, El-Shafei AM., Synthetic approaches and biological evaluation of some new sulfonate ester-containing quinazoline derivatives as potentially active antimicrobial agents. Boll. Chim. Farmaceutico., 1995, 134: 209-215. [10] Habib OMO, Hassan HM, El-Mekabaty A., Novel quinazolinone derivatives: synthesis and antimicrobial activity. Med Chem. Res, 2012, DOI 10.1007/s00044-012-0079-x. [11] El-Mekabaty A. Improvement of lubricating oils characters using novel additives. International Journal of Modern Organic Chemistry, 2012, 1: 72-95. [12] Habib OMO, Hassan HM, El-Mekabaty A., Studies on Some Benzoxazine-4-one Derivatives with Potential Biological Activity. American Journal of Organic Chemistry, 2012, 2: 45-51. [13] Girges MM, Abou El-Zahab MM, Hanna MA., Facile Synthesis and Biological Activity of Sulfonate Ester-Containing ImidazolylpyridineImidazo(4,5-b)Pyridine and Imidazo(5,1:2,3) Imidazo(4,5-b)Pyridine Derivatives. Collect Czech. Chem. Commun., 1989, 54: 1096-1103.

Copyright 2013 by Modern Scientific Press Company, Florida, USA

Int. J. Modern Org. Chem. 2013, 2(1): 11-25

25

[14] Tobbe M, Spitzer W, Victor F, Miller S, Lee C, Sattelberg T, Mckinney E, Tang C., Antirhino/Enteroviral Vinylacetylene Benzimidazoles: A Study of Their Activity and Oral Plasma Levels in Mice. J. Med. Chem., 1997, 40: 39373946. [15] Porcari A, Devivar R, Kuera L, Drach J, Townsend L., Design, Synthesis and Antiviral Evaluations of 1-(Substitutedbenzyl)-2-Substituted-5,6-dichlorobenzimidazoles as Nonnucleoside Analogues of 2,5,6-Trichloro-1-(-D-ribofuranosyl)benzimidazole. J. Med. Chem., 1998, 41: 12521262. [16] Roth M, Morningstar M, Boyer P, Hughes S, Bukheit R, Michejda C., Synthesis and Biological Activity of Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 2-Aryl-Substituted Benzimidazoles. J. Med. Chem., 1997, 40: 41994207. [17] Mrgawa M, Girardet J, Walker J, Koszalka G, Chamberlain S, Drach J, Townsend L., Design, Synthesis, and Antiviral Activity of -Nucleosides: D- and L-Isomers of Lyxofuranosyl and (5Deoxylyxofuranosyl)benzimidazoles. J. Med. Chem.,1998, 41: 12421251. [18] Tamm I, Sehgal P., Halobenzimidazole Ribosides and RNA Synthesis of Cells and Viruses. Adv. Virus Res., 1979, 22: 187192. [19] Baltork M, Moghadam M, Tangestaninejad S, Mirkhani V, Zolfigol M, Hojati S., Silica Sulfuric Acid Catalyzed Synthesis of Benzoxazole, Benzimidazoles and Oxazolo [4,5-b]pyridines Under Heterogeneous and Solvent-Free Conditions. J. Iran. Chem. Soc., 2008, 5: S65-S70. [20] Bondock S, Fadaly W, Metwally MA., Synthesis and antimicrobial activity of some new thiazole, thiophene and pyrazole derivatives containing benzothiazole moiety. Eur. J. Med. Chem., 2010, 45: 3692-3701. [21] Bondock S, Fadaly W, Metwally MA. Enaminonitrile in heterocyclic synthesis: Synthesis and antimicrobial evaluation of some new pyrazole, isoxazole and pyrimidine derivatives incorporating a benzothiazole moiety. Eur. J. Med. Chem., 2009, 43: 2342-2349. [22] Holla BS, Poorjary NK, Rao SB, Shivananda MK. New bis-aminomercaptotriazoles and bistriazolothiadiazoles as possible anticancer agents. Eur. J. Med. Chem., 2002, 37: 511517. [23] Holla BS, Akberali PM, Shivananda MK. Studies on nitrophenylfuran derivatives-Part XII. Synthesis, characterization, antibacterial and antiviral activities of some nitrophenylfurfurylidene- 1,2,4-triazolo[3,4-b]-1,3,4 thiadiazines. II Farmaco., 2001, 56: 919 927.

Copyright 2013 by Modern Scientific Press Company, Florida, USA